Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles Theuer currently holds 50,000 shares of Tracon Pharmaceuticals, Inc. (TCON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Theuer has been a net buyer of TCON stock. They have purchased $749.2K and sold $216.8K worth of shares.
Charles Theuer's most recent insider trade was on Jun 17, 2026, when they sold 50,000 shares at $0.00 per share.
Charles Theuer serves as Executive at Tracon Pharmaceuticals, Inc. (TCON). They have executed 69 insider transactions totaling $966.0K over their tenure at the company.
Charles Theuer holds the position of Executive at Tracon Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Charles Theuer has shown a buying trading pattern, with $749.2K in total purchases and $216.8K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Charles Theuer was on Jan 27, 2021, when they purchased $98.8K worth of TCON shares. This transaction involved 11,000 shares at $8.98 per share.
Charles Theuer currently owns 50,000 shares of Tracon Pharmaceuticals, Inc. (TCON), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles Theuer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles Theuer has 69 Form 4 filings on record as an insider at Tracon Pharmaceuticals, Inc..
Set alerts for Charles Theuer and 40,000+ other insiders.